Genex Pharmaceutical Inc (GENX)
Genex Pharmaceutical Inc. is a China-based healthcare company listed on OTC Markets under the symbol GENX. Through its common stock, investors are exposed to the operations of an issuer that develops, produces, and distributes Reconstituted Bone Xenograft (RBX), a medical device designed to support and accelerate bone healing. The company’s products are distributed in the People’s Republic of China, with a customer base that includes about 500 hospitals and other medical device customers. Founded in 2003, Genex Pharmaceutical is headquartered in Tianjin, China.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Market Cap |
|---|---|---|---|---|---|---|
|
OTC-GENX
|
Not available
|
Not available
|
Not available
|
Fair
|
0.0%
|
1.784 K
|
